SlideShare a Scribd company logo
1 of 14
Download to read offline
ERIC SCHMIDT
BETHANY MOORE, ALEX HEUBECK, AND ZACHARY DECKER
CHRISTOPHER WILSON, BIOVENTUS
12/12/14
• The Baby Boomers (~75 million
Americans)
• The average baby boomer will be 65 by
the year 2020
• Osteoporosis
• 55% of people currently 50 years old
have low bone mass or Osteoporosis
• Osteoporosis causes 1.5 million fractures
a year
Curry, Linda C., Mildred O. Hogstel, Pamela J. Frable, and Charles Walker. "Bone Health Among Aging Baby Boomers.“ Internet Scientific
Publications. N.p.,n.d. Web. 09 Dec. 2014.
• Current bone grafting techniques require donor tissue
• New products (INFUSE®, Amplify®) use BMP-2
• Complications with holding BMP-2 together, burst release
• In a study of 151 patients who underwent spinal fusions using Infuse, 35 had
complications due to the high dosage use
• Bioventus solution: Hydrogel molds + Calcium Phosphate
granules + BMP-2
• Only problem is the homogenous
mixing of these components
Shields, Lisa, George Raque, Steven Glassman, Mitchell Campbell, Todd Vitaz, John Harping, and Christopher Shields. "Adverse Effects
Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion." Adverse Effects
Associated With High-Dose Recombinant Human... : Spine. Spine, 1 Mar. 2006. Web. 02 Oct. 2014.
• Primary Concept
• Pros:
• Easily packaged
• Simple procedure
• Most promising design
• Cons:
• Small amount of waste
• Forces could shear gel
• Pros:
• Simple procedure
• No gel shearing
• Cons:
• No real mixing agent
• Pros:
• Simple procedure
• Cons:
• Low reproducibility
• Rotational forces could sheer gel
n=1 Not Statistically Significant
n=1 Not Statistically Significant
1. Generate device concepts
• Completed
2. Evaluate designs through modeling and testing
• Computational modelling
• 3D printing prototypes
• Hydrogel characterization, Mechanical properties, Protein/Granule
uniformity using microscopy, and Preservation of bioactivity
3. Optimize device and procedure
• Reproducibility, Low cost, Ease of use
• *Incorporate porosity in mold for increased efficacy*
• Computational Modeling (Ansys Fluent)
• Hydrogel Characterization
• 3D printing prototypes
• Fluorescent Microscopy
• 5 μm thick slices taken at several points along length of mold
• BMP-2 Stained with fluorescently tagged antibody for viewing
• Comparative image analysis to ensure
uniformity (<10% deviation)
• Calcium phosphate granules also quantified
and compared between regions (<10%
deviation)
• Test for bioactivity preservation of BMP2 in final mold
• Test for mechanical uniformity of mold
• Optimization
• Simplify procedure
• Determine cost effective/biocompatible
materials
• Reproducibility
• Repeat experiments for statistical significance, consistency
• *Porosity within the mold*
• Device will be:
• Easy to use
• Cheap
• Disposable/Sterile
• Procedure will be:
• Highly repeatable
• Few steps
• Final mold will be:
• Homogenously mixed so that:
• BMP-2 evenly distributed throughout
mold and on granules (<10% deviation)
• Granules uniform throughout mold (<10%
deviation)
• Mechanical properties uniform (<10%
deviation)
• Preservation of BMP-2 bioactivity
within mold (pass/fail)
• *Porosity for blood vessel
penetration*
Task Completion Date Progress
Research Prior Art October 15th Completed
Create Concepts November 1st Completed
3D Render Concepts December 1st Completed
Characterize Hydrogel February 1st In Progress
Computational Modeling February 15th In Progress
Prototype Concepts February 15th In Progress
Fluorescence Microscopy March 15th Not Completed
MechanicalTesting March 15th Not Completed
Bioactivity Testing March 15th Not Completed
Repeatability April 1st Not Completed
Materials Research April 15th Not Completed
Procedure Optimization April 15th Not Completed
Incorporate Porosity* April 15th Not Completed
•Chris, Eric and the Bioventus team for their advice and
resources
•Dr. Xin Brown for her help with the TA AR 2000
Rheometer
•Dr. Phil Allen training us on some of the basics of
fluorescent microscopy

More Related Content

Similar to Schmidt_12-8-14

Act annual-shareholders'-meeting-10.22.13
Act annual-shareholders'-meeting-10.22.13Act annual-shareholders'-meeting-10.22.13
Act annual-shareholders'-meeting-10.22.13John Redaelli
 
SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...
SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...
SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...SmartBone
 
Literature Survey
Literature SurveyLiterature Survey
Literature SurveyGanesh Elan
 
Bone graft and its substitute
Bone graft and its substituteBone graft and its substitute
Bone graft and its substituteDr Kushal Shah
 
A Manufacturer’s Perspective on Innovations in Biomanufacturing
A Manufacturer’s Perspective on Innovations in BiomanufacturingA Manufacturer’s Perspective on Innovations in Biomanufacturing
A Manufacturer’s Perspective on Innovations in BiomanufacturingKBI Biopharma
 
Perfusion Culture System
Perfusion Culture SystemPerfusion Culture System
Perfusion Culture Systembandhan_daripa
 
Bone grafts in dentistry
Bone grafts in dentistryBone grafts in dentistry
Bone grafts in dentistryKirtiRanka1
 
Analysis of buccolingual dimensional changes of the extraction socket using t...
Analysis of buccolingual dimensional changes of the extraction socket using t...Analysis of buccolingual dimensional changes of the extraction socket using t...
Analysis of buccolingual dimensional changes of the extraction socket using t...MD Abdul Haleem
 
REGENERATIVE ENDODONTICS.pptx
REGENERATIVE ENDODONTICS.pptxREGENERATIVE ENDODONTICS.pptx
REGENERATIVE ENDODONTICS.pptxDrRutikaNaik
 
Bone regeneration and substitutes
Bone regeneration and substitutes  Bone regeneration and substitutes
Bone regeneration and substitutes kyaw tint
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...KBI Biopharma
 
biocompatibility of polymers.pptx
biocompatibility of polymers.pptxbiocompatibility of polymers.pptx
biocompatibility of polymers.pptx01003051130
 
Implant Lit Review- Winnett 2016- NSAIDs use might impair osseointegration
Implant Lit Review- Winnett 2016- NSAIDs use might impair osseointegrationImplant Lit Review- Winnett 2016- NSAIDs use might impair osseointegration
Implant Lit Review- Winnett 2016- NSAIDs use might impair osseointegrationHosan Park
 

Similar to Schmidt_12-8-14 (20)

Act annual-shareholders'-meeting-10.22.13
Act annual-shareholders'-meeting-10.22.13Act annual-shareholders'-meeting-10.22.13
Act annual-shareholders'-meeting-10.22.13
 
SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...
SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...
SmartBone: the innovative bone substitute for oral surgery and maxillofacial ...
 
Literature Survey
Literature SurveyLiterature Survey
Literature Survey
 
Ridge preservation copy
Ridge preservation copyRidge preservation copy
Ridge preservation copy
 
SYRCLE_Sloff mini symposium sr animal studies 30082012
SYRCLE_Sloff mini symposium sr animal studies 30082012SYRCLE_Sloff mini symposium sr animal studies 30082012
SYRCLE_Sloff mini symposium sr animal studies 30082012
 
Bone graft and its substitute
Bone graft and its substituteBone graft and its substitute
Bone graft and its substitute
 
A Manufacturer’s Perspective on Innovations in Biomanufacturing
A Manufacturer’s Perspective on Innovations in BiomanufacturingA Manufacturer’s Perspective on Innovations in Biomanufacturing
A Manufacturer’s Perspective on Innovations in Biomanufacturing
 
Organs On Chips (OOC)
Organs On Chips (OOC)Organs On Chips (OOC)
Organs On Chips (OOC)
 
Perfusion Culture System
Perfusion Culture SystemPerfusion Culture System
Perfusion Culture System
 
Bone grafts in dentistry
Bone grafts in dentistryBone grafts in dentistry
Bone grafts in dentistry
 
Analysis of buccolingual dimensional changes of the extraction socket using t...
Analysis of buccolingual dimensional changes of the extraction socket using t...Analysis of buccolingual dimensional changes of the extraction socket using t...
Analysis of buccolingual dimensional changes of the extraction socket using t...
 
eye banking
eye banking eye banking
eye banking
 
REGENERATIVE ENDODONTICS.pptx
REGENERATIVE ENDODONTICS.pptxREGENERATIVE ENDODONTICS.pptx
REGENERATIVE ENDODONTICS.pptx
 
Biocartilage
BiocartilageBiocartilage
Biocartilage
 
Bone regeneration and substitutes
Bone regeneration and substitutes  Bone regeneration and substitutes
Bone regeneration and substitutes
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
 
biocompatibility of polymers.pptx
biocompatibility of polymers.pptxbiocompatibility of polymers.pptx
biocompatibility of polymers.pptx
 
Biomaterials. Merging Materials Science with Biology.
Biomaterials. Merging Materials Science with Biology.Biomaterials. Merging Materials Science with Biology.
Biomaterials. Merging Materials Science with Biology.
 
biofunctional prosthetic system
biofunctional prosthetic systembiofunctional prosthetic system
biofunctional prosthetic system
 
Implant Lit Review- Winnett 2016- NSAIDs use might impair osseointegration
Implant Lit Review- Winnett 2016- NSAIDs use might impair osseointegrationImplant Lit Review- Winnett 2016- NSAIDs use might impair osseointegration
Implant Lit Review- Winnett 2016- NSAIDs use might impair osseointegration
 

Schmidt_12-8-14

  • 1. ERIC SCHMIDT BETHANY MOORE, ALEX HEUBECK, AND ZACHARY DECKER CHRISTOPHER WILSON, BIOVENTUS 12/12/14
  • 2. • The Baby Boomers (~75 million Americans) • The average baby boomer will be 65 by the year 2020 • Osteoporosis • 55% of people currently 50 years old have low bone mass or Osteoporosis • Osteoporosis causes 1.5 million fractures a year Curry, Linda C., Mildred O. Hogstel, Pamela J. Frable, and Charles Walker. "Bone Health Among Aging Baby Boomers.“ Internet Scientific Publications. N.p.,n.d. Web. 09 Dec. 2014.
  • 3. • Current bone grafting techniques require donor tissue • New products (INFUSE®, Amplify®) use BMP-2 • Complications with holding BMP-2 together, burst release • In a study of 151 patients who underwent spinal fusions using Infuse, 35 had complications due to the high dosage use • Bioventus solution: Hydrogel molds + Calcium Phosphate granules + BMP-2 • Only problem is the homogenous mixing of these components Shields, Lisa, George Raque, Steven Glassman, Mitchell Campbell, Todd Vitaz, John Harping, and Christopher Shields. "Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion." Adverse Effects Associated With High-Dose Recombinant Human... : Spine. Spine, 1 Mar. 2006. Web. 02 Oct. 2014.
  • 4. • Primary Concept • Pros: • Easily packaged • Simple procedure • Most promising design • Cons: • Small amount of waste • Forces could shear gel
  • 5. • Pros: • Simple procedure • No gel shearing • Cons: • No real mixing agent
  • 6. • Pros: • Simple procedure • Cons: • Low reproducibility • Rotational forces could sheer gel
  • 7. n=1 Not Statistically Significant
  • 8. n=1 Not Statistically Significant
  • 9. 1. Generate device concepts • Completed 2. Evaluate designs through modeling and testing • Computational modelling • 3D printing prototypes • Hydrogel characterization, Mechanical properties, Protein/Granule uniformity using microscopy, and Preservation of bioactivity 3. Optimize device and procedure • Reproducibility, Low cost, Ease of use • *Incorporate porosity in mold for increased efficacy*
  • 10. • Computational Modeling (Ansys Fluent) • Hydrogel Characterization • 3D printing prototypes • Fluorescent Microscopy • 5 μm thick slices taken at several points along length of mold • BMP-2 Stained with fluorescently tagged antibody for viewing • Comparative image analysis to ensure uniformity (<10% deviation) • Calcium phosphate granules also quantified and compared between regions (<10% deviation)
  • 11. • Test for bioactivity preservation of BMP2 in final mold • Test for mechanical uniformity of mold • Optimization • Simplify procedure • Determine cost effective/biocompatible materials • Reproducibility • Repeat experiments for statistical significance, consistency • *Porosity within the mold*
  • 12. • Device will be: • Easy to use • Cheap • Disposable/Sterile • Procedure will be: • Highly repeatable • Few steps • Final mold will be: • Homogenously mixed so that: • BMP-2 evenly distributed throughout mold and on granules (<10% deviation) • Granules uniform throughout mold (<10% deviation) • Mechanical properties uniform (<10% deviation) • Preservation of BMP-2 bioactivity within mold (pass/fail) • *Porosity for blood vessel penetration*
  • 13. Task Completion Date Progress Research Prior Art October 15th Completed Create Concepts November 1st Completed 3D Render Concepts December 1st Completed Characterize Hydrogel February 1st In Progress Computational Modeling February 15th In Progress Prototype Concepts February 15th In Progress Fluorescence Microscopy March 15th Not Completed MechanicalTesting March 15th Not Completed Bioactivity Testing March 15th Not Completed Repeatability April 1st Not Completed Materials Research April 15th Not Completed Procedure Optimization April 15th Not Completed Incorporate Porosity* April 15th Not Completed
  • 14. •Chris, Eric and the Bioventus team for their advice and resources •Dr. Xin Brown for her help with the TA AR 2000 Rheometer •Dr. Phil Allen training us on some of the basics of fluorescent microscopy